Introduction. Trabectedin treatment in GYN cancers
1Area Clínica de Oncologia, Ginecológica Fundación Instituto Valenciano de Oncología, Valencia, Spain. apoveda@fivo.org
Summary
Ovarian cancer is a leading cause of cancer death in women, with high fatality rates globally. Early detection and treatment are crucial for improving outcomes in this common gynecological malignancy.
Area of Science:
- Gynecology
- Oncology
- Epidemiology
Background:
- Ovarian cancer is the second most common gynecological cancer.
- It accounts for 5% of all cancers in women.
- Ovarian cancer has the highest case-fatality rate among gynecological malignancies.
Purpose of the Study:
- To highlight the significant public health burden of ovarian cancer.
- To provide current statistics on ovarian cancer incidence and mortality.
- To underscore the urgency of addressing ovarian cancer challenges.
Main Methods:
- Data compilation from European Union and United States cancer registries.
- Analysis of incidence and mortality statistics for ovarian cancer.
- Review of epidemiological trends in gynecological malignancies.
Main Results:
- Approximately 48,000 new cases and 31,000 deaths occur annually in the European Union.
- Approximately 25,500 new cases and 16,000 deaths are reported annually in the United States.
- Ovarian cancer demonstrates a high mortality-to-incidence ratio compared to other gynecological cancers.
Conclusions:
- Ovarian cancer represents a substantial global health issue.
- Significant numbers of new cases and deaths highlight the need for effective interventions.
- The high fatality rate necessitates continued research and improved patient management strategies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...